{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T04:47:29Z","timestamp":1776314849449,"version":"3.50.1"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA248741"],"award-info":[{"award-number":["R01CA248741"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-026-04330-1","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T06:46:45Z","timestamp":1772261205000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Enhanced antitumor efficacy of combined targeting of adenosine A2B receptor and PD-1 is mediated via multiple effects on different cell populations within tumor microenvironment"],"prefix":"10.1007","volume":"75","author":[{"given":"Shuxiao","family":"Guan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cankun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Amann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju Hwan","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David P.","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"4330_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008189","author":"DP Carbone","year":"2024","unstructured":"Carbone DP, Ciuleanu TE, Schenker M, Cobo M, Bordenave S, Juan-Vidal O et al (2024) Four-year clinical update and treatment switching-adjusted outcomes with first-line nivolumab plus ipilimumab with chemotherapy for metastatic non-small cell lung cancer in the CheckMate 9LA randomized trial. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2023-008189","journal-title":"J Immunother Cancer"},{"issue":"7","key":"4330_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1200\/JCO.20.01605","volume":"39","author":"H Borghaei","year":"2021","unstructured":"Borghaei H, Gettinger S, Vokes EE, Chow LQM, Burgio MA, de Castro Carpeno J et al (2021) Five-year outcomes from the randomized, phase III trials CheckMate 017 and 057: nivolumab versus docetaxel in previously treated non-small-cell lung cancer. J Clin Oncol 39(7):723\u2013733","journal-title":"J Clin Oncol"},{"issue":"10","key":"4330_CR3","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/S1470-2045(19)30407-3","volume":"20","author":"SJ Antonia","year":"2019","unstructured":"Antonia SJ, Borghaei H, Ramalingam SS, Horn L, De Castro Carpeno J, Pluzanski A et al (2019) Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis. Lancet Oncol 20(10):1395\u20131408","journal-title":"Lancet Oncol"},{"key":"4330_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1434118","volume":"15","author":"Y Han","year":"2024","unstructured":"Han Y, Dong C, Hu M, Wang X, Wang G (2024) Unlocking the adenosine receptor mechanism of the tumour immune microenvironment. Front Immunol 15:1434118","journal-title":"Front Immunol"},{"issue":"6","key":"4330_CR5","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","volume":"36","author":"D Boison","year":"2019","unstructured":"Boison D, Yegutkin GG (2019) Adenosine metabolism: emerging concepts for cancer therapy. Cancer Cell 36(6):582\u2013596","journal-title":"Cancer Cell"},{"key":"4330_CR6","doi-asserted-by":"crossref","unstructured":"Sek K, Molck C, Stewart GD, Kats L, Darcy PK, Beavis PA. (2018) Targeting adenosine receptor signaling in cancer immunotherapy. Int J Mol Sci 19(12)","DOI":"10.3390\/ijms19123837"},{"issue":"11","key":"4330_CR7","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/jnci\/djad091","volume":"115","author":"JV Evans","year":"2023","unstructured":"Evans JV, Suman S, Goruganthu MUL, Tchekneva EE, Guan S, Arasada RR et al (2023) Improving combination therapies: targeting A2B-adenosine receptor to modulate metabolic tumor microenvironment and immunosuppression. J Natl Cancer Inst 115(11):1404\u20131419","journal-title":"J Natl Cancer Inst"},{"key":"4330_CR8","doi-asserted-by":"crossref","unstructured":"Liu H, Kuang X, Zhang Y, Ye Y, Li J, Liang L, et al. (2020) ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis. Cancer Cell 37(3):324\u201339 e8","DOI":"10.1016\/j.ccell.2020.02.006"},{"issue":"1","key":"4330_CR9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1158\/2159-8290.CD-19-0980","volume":"10","author":"L Fong","year":"2020","unstructured":"Fong L, Hotson A, Powderly JD, Sznol M, Heist RS, Choueiri TK et al (2020) Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. Cancer Discov 10(1):40\u201353","journal-title":"Cancer Discov"},{"issue":"1","key":"4330_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01733-x","volume":"22","author":"C Xia","year":"2023","unstructured":"Xia C, Yin S, To KKW, Fu L (2023) CD39\/CD73\/A2AR pathway and cancer immunotherapy. Mol Cancer 22(1):44","journal-title":"Mol Cancer"},{"issue":"6","key":"4330_CR11","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.4049\/jimmunol.1400578","volume":"193","author":"SV Ryzhov","year":"2014","unstructured":"Ryzhov SV, Pickup MW, Chytil A, Gorska AE, Zhang Q, Owens P et al (2014) Role of TGF-beta signaling in generation of CD39+CD73+ myeloid cells in tumors. J Immunol 193(6):3155\u20133164","journal-title":"J Immunol"},{"issue":"3","key":"4330_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/cbf.4010","volume":"42","author":"LA Marin-Aquino","year":"2024","unstructured":"Marin-Aquino LA, Mora-Garcia ML, Moreno-Lafont MC, Garcia-Rocha R, Montesinos-Montesinos JJ, Lopez-Santiago R et al (2024) Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A(2A)R\/A(2B)R and the production of TGF-beta1. Cell Biochem Funct 42(3):e4010","journal-title":"Cell Biochem Funct"},{"issue":"1","key":"4330_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Khan L, Bensler NP, Bose P, De Carvalho DD (2018) TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun 9(1):4692","journal-title":"Nat Commun"},{"issue":"12","key":"4330_CR14","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1158\/0008-5472.CAN-19-3954","volume":"80","author":"G Vasiukov","year":"2020","unstructured":"Vasiukov G, Novitskaya T, Zijlstra A, Owens P, Ye F, Zhao Z et al (2020) Myeloid Cell-Derived TGFbeta Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms. Cancer Res 80(12):2628\u20132638","journal-title":"Cancer Res"},{"key":"4330_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002503","author":"M Kim","year":"2021","unstructured":"Kim M, Min YK, Jang J, Park H, Lee S, Lee CH (2021) Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2021-002503","journal-title":"J Immunother Cancer"},{"issue":"4","key":"4330_CR16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massague J (2019) Transforming growth factor-beta signaling in immunity and cancer. Immunity 50(4):924\u2013940","journal-title":"Immunity"},{"issue":"6","key":"4330_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252424","volume":"16","author":"G Vasiukov","year":"2021","unstructured":"Vasiukov G, Menshikh A, Owens P, Novitskaya T, Hurley P, Blackwell T et al (2021) Adenosine\/TGFbeta axis in regulation of mammary fibroblast functions. PLoS ONE 16(6):e0252424","journal-title":"PLoS ONE"},{"issue":"9","key":"4330_CR18","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1158\/2326-6066.CIR-16-0365","volume":"5","author":"HY Li","year":"2017","unstructured":"Li HY, McSharry M, Bullock B, Nguyen TT, Kwak J, Poczobutt JM et al (2017) The Tumor Microenvironment Regulates Sensitivity of Murine Lung Tumors to PD-1\/PD-L1 Antibody Blockade. Cancer Immunol Res 5(9):767\u2013777","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"4330_CR19","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH et al (2021) Inference and analysis of cell-cell communication using Cell Chat. Nat Commun 12(1):1088","journal-title":"Nat Commun"},{"issue":"10","key":"4330_CR20","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1158\/2159-8290.CD-20-1285","volume":"11","author":"A Sinjab","year":"2021","unstructured":"Sinjab A, Han G, Treekitkarnmongkol W, Hara K, Brennan PM, Dang M et al (2021) Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing. Cancer Discov 11(10):2506\u20132523","journal-title":"Cancer Discov"},{"key":"4330_CR21","doi-asserted-by":"crossref","unstructured":"Hornburg M, Desbois M, Lu S, Guan Y, Lo AA, Kaufman S, et al. (2021) Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer. Cancer Cell 39(7):928\u201344 e6","DOI":"10.1016\/j.ccell.2021.04.004"},{"key":"4330_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207561","author":"DM Zajonc","year":"2020","unstructured":"Zajonc DM (2020) Unconventional peptide presentation by classical MHC class I and implications for T and NK cell activation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21207561","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4330_CR23","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M et al (2020) Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 21(6):341\u2013352","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"4330_CR24","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","volume":"15","author":"CI Diakos","year":"2014","unstructured":"Diakos CI, Charles KA, McMillan DC, Clarke SJ (2014) Cancer-related inflammation and treatment effectiveness. Lancet Oncol 15(11):e493-503","journal-title":"Lancet Oncol"},{"issue":"11","key":"4330_CR25","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423\u20131437","journal-title":"Nat Med"},{"issue":"1","key":"4330_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-024-00522-z","volume":"8","author":"S Wang","year":"2024","unstructured":"Wang S, Wang J, Chen Z, Luo J, Guo W, Sun L et al (2024) Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance. NPJ Precis Oncol 8(1):31","journal-title":"NPJ Precis Oncol"},{"issue":"7","key":"4330_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"RY Ma","year":"2022","unstructured":"Ma RY, Black A, Qian BZ (2022) Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol 43(7):546\u2013563","journal-title":"Trends Immunol"},{"issue":"12","key":"4330_CR28","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.it.2023.10.007","volume":"44","author":"I Nasir","year":"2023","unstructured":"Nasir I, McGuinness C, Poh AR, Ernst M, Darcy PK, Britt KL (2023) Tumor macrophage functional heterogeneity can inform the development of novel cancer therapies. Trends Immunol 44(12):971\u2013985","journal-title":"Trends Immunol"},{"key":"4330_CR29","doi-asserted-by":"crossref","unstructured":"Lei Z, Tang R, Wu Y, Mao C, Xue W, Shen J, et al. (2024) TGF-beta1 induces PD-1 expression in macrophages through SMAD3\/STAT3 cooperative signaling in chronic inflammation. JCI Insight 9(7)","DOI":"10.1172\/jci.insight.165544"},{"issue":"1","key":"4330_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21407-w","volume":"12","author":"N Ochocka","year":"2021","unstructured":"Ochocka N, Segit P, Walentynowicz KA, Wojnicki K, Cyranowski S, Swatler J et al (2021) Single-cell RNA sequencing reveals functional heterogeneity of glioma-associated brain macrophages. Nat Commun 12(1):1151","journal-title":"Nat Commun"},{"issue":"1","key":"4330_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49916-4","volume":"15","author":"GR Guimaraes","year":"2024","unstructured":"Guimaraes GR, Maklouf GR, Teixeira CE, de Oliveira Santos L, Tessarollo NG, de Toledo NE et al (2024) Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcome. Nat Commun 15(1):5694","journal-title":"Nat Commun"},{"issue":"3","key":"4330_CR32","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng S, Li Z, Gao R, Xing B, Gao Y, Yang Y et al (2021) A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184(3):792-809 e23","journal-title":"Cell"},{"issue":"10","key":"4330_CR33","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1158\/1541-7786.MCR-12-0275","volume":"10","author":"LR Bohrer","year":"2012","unstructured":"Bohrer LR, Schwertfeger KL (2012) Macrophages promote fibroblast growth factor receptor-driven tumor cell migration and invasion in a CXCR2-dependent manner. Mol Cancer Res 10(10):1294\u20131305","journal-title":"Mol Cancer Res"},{"issue":"10","key":"4330_CR34","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1158\/1541-7786.MCR-18-0933","volume":"17","author":"J Yang","year":"2019","unstructured":"Yang J, Zeng Z, Qiao L, Jiang X, Ma J, Wang J et al (2019) Semaphorin 4c promotes macrophage recruitment and angiogenesis in breast cancer. Mol Cancer Res 17(10):2015\u20132028","journal-title":"Mol Cancer Res"},{"key":"4330_CR35","doi-asserted-by":"crossref","unstructured":"Daniel B, Belk JA, Meier SL, Chen AY, Sandor K, Czimmerer Z, et al. (2023) Macrophage inflammatory and regenerative response periodicity is programmed by cell cycle and chromatin state. Mol Cell 83(1):121\u201338 e7","DOI":"10.1016\/j.molcel.2022.11.017"},{"issue":"1","key":"4330_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","volume":"9","author":"Z Deng","year":"2024","unstructured":"Deng Z, Fan T, Xiao C, Tian H, Zheng Y, Li C et al (2024) TGF-beta signaling in health, disease, and therapeutics. Signal Transduct Target Ther 9(1):61","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4330_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y (2023) Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Ther 8(1):92","journal-title":"Signal Transduct Target Ther"},{"issue":"7745","key":"4330_CR38","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ et al (2019) The single-cell transcriptional landscape of mammalian organogenesis. Nature 566(7745):496\u2013502","journal-title":"Nature"},{"issue":"4","key":"4330_CR39","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.4049\/jimmunol.0900191","volume":"183","author":"PL Bollyky","year":"2009","unstructured":"Bollyky PL, Falk BA, Long SA, Preisinger A, Braun KR, Wu RP et al (2009) CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol 183(4):2232\u20132241","journal-title":"J Immunol"},{"issue":"1","key":"4330_CR40","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1038\/s41467-021-26352-2","volume":"12","author":"A Laine","year":"2021","unstructured":"Laine A, Labiad O, Hernandez-Vargas H, This S, Sanlaville A, Leon S et al (2021) Regulatory T cells promote cancer immune-escape through integrin alphavbeta8-mediated TGF-beta activation. Nat Commun 12(1):6228","journal-title":"Nat Commun"},{"issue":"8016","key":"4330_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41586-024-07443-8","volume":"630","author":"SA Yamada-Hunter","year":"2024","unstructured":"Yamada-Hunter SA, Theruvath J, McIntosh BJ, Freitas KA, Lin F, Radosevich MT et al (2024) Engineered CD47 protects T cells for enhanced antitumour immunity. Nature 630(8016):457\u2013465","journal-title":"Nature"},{"issue":"1","key":"4330_CR42","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2111909","volume":"11","author":"PR Nath","year":"2022","unstructured":"Nath PR, Pal-Nath D, Kaur S, Gangaplara A, Meyer TJ, Cam MC et al (2022) Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice. Oncoimmunology 11(1):2111909","journal-title":"Oncoimmunology"},{"key":"4330_CR43","doi-asserted-by":"crossref","unstructured":"Hu H, Piotrowska Z, Hare PJ, Chen H, Mulvey HE, Mayfield A, et al. (2021) Three subtypes of lung cancer fibroblasts define distinct therapeutic paradigms. Cancer Cell 39(11):1531\u201347 e10","DOI":"10.1016\/j.ccell.2021.09.003"},{"issue":"3","key":"4330_CR44","doi-asserted-by":"publisher","first-page":"934","DOI":"10.4049\/jimmunol.1403038","volume":"195","author":"D Ito","year":"2015","unstructured":"Ito D, Nojima S, Nishide M, Okuno T, Takamatsu H, Kang S et al (2015) mTOR complex signaling through the SEMA4A-Plexin B2 axis is required for optimal activation and differentiation of CD8+ T cells. J Immunol 195(3):934\u2013943","journal-title":"J Immunol"},{"issue":"1","key":"4330_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z (2020) Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun 11(1):5120","journal-title":"Nat Commun"},{"issue":"2","key":"4330_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys R, Saelens W, Saeys Y (2020) NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods 17(2):159\u2013162","journal-title":"Nat Methods"},{"issue":"2","key":"4330_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.canlet.2016.04.012","volume":"376","author":"SK Hong","year":"2016","unstructured":"Hong SK, Park JR, Kwon OS, Kim KT, Bae GY, Cha HJ (2016) Induction of integrin beta3 by sustained ERK activity promotes the invasiveness of TGFbeta-induced mesenchymal tumor cells. Cancer Lett 376(2):339\u2013346","journal-title":"Cancer Lett"},{"issue":"2","key":"4330_CR48","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3892\/or.2016.4869","volume":"36","author":"L Shen","year":"2016","unstructured":"Shen L, Yang M, Lin Q, Zhang Z, Zhu B, Miao C (2016) COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. Oncol Rep 36(2):877\u2013885","journal-title":"Oncol Rep"},{"issue":"1","key":"4330_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s40425-019-0556-6","volume":"7","author":"DE Kuczek","year":"2019","unstructured":"Kuczek DE, Larsen AMH, Thorseth ML, Carretta M, Kalvisa A, Siersbaek MS et al (2019) Collagen density regulates the activity of tumor-infiltrating T cells. J Immunother Cancer 7(1):68","journal-title":"J Immunother Cancer"},{"key":"4330_CR50","doi-asserted-by":"crossref","unstructured":"Yang L, Teng Y, Han TP, Li FG, Yue WT, Wang ZT. (2017) Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer. Genet Mol Res 16(2)","DOI":"10.4238\/gmr16029617"},{"issue":"8","key":"4330_CR51","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/cdd.2014.228","volume":"22","author":"YW Moon","year":"2015","unstructured":"Moon YW, Rao G, Kim JJ, Shim HS, Park KS, An SS et al (2015) LAMC2 enhances the metastatic potential of lung adenocarcinoma. Cell Death Differ 22(8):1341\u20131352","journal-title":"Cell Death Differ"},{"issue":"2","key":"4330_CR52","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.bjc.6605154","volume":"101","author":"XN Meng","year":"2009","unstructured":"Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J et al (2009) Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 101(2):327\u2013334","journal-title":"Br J Cancer"},{"key":"4330_CR53","doi-asserted-by":"crossref","unstructured":"Zhang YE. (2017) Non-Smad Signaling Pathways of the TGF-beta Family. Cold Spring Harb Perspect Biol 9(2)","DOI":"10.1101\/cshperspect.a022129"},{"key":"4330_CR54","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/ncomms1734","volume":"3","author":"A Akhmetshina","year":"2012","unstructured":"Akhmetshina A, Palumbo K, Dees C, Bergmann C, Venalis P, Zerr P et al (2012) Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis. Nat Commun 3:735","journal-title":"Nat Commun"},{"key":"4330_CR55","doi-asserted-by":"crossref","unstructured":"Ungefroren H, Gieseler F, Kaufmann R, Settmacher U, Lehnert H, Rauch BH. (2018) Signaling Crosstalk of TGF-beta\/ALK5 and PAR2\/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer. Int J Mol Sci 19(6).","DOI":"10.3390\/ijms19061568"},{"issue":"4","key":"4330_CR56","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/jb\/mvs089","volume":"152","author":"M Horiguchi","year":"2012","unstructured":"Horiguchi M, Ota M, Rifkin DB (2012) Matrix control of transforming growth factor-beta function. J Biochem 152(4):321\u2013329","journal-title":"J Biochem"},{"issue":"1","key":"4330_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-023-00956-w","volume":"30","author":"SF Wang","year":"2023","unstructured":"Wang SF, Tseng LM, Lee HC (2023) Role of mitochondrial alterations in human cancer progression and cancer immunity. J Biomed Sci 30(1):61","journal-title":"J Biomed Sci"},{"issue":"9","key":"4330_CR58","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1093\/hmg\/ddp069","volume":"18","author":"JS Park","year":"2009","unstructured":"Park JS, Sharma LK, Li H, Xiang R, Holstein D, Wu J et al (2009) A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet 18(9):1578\u20131589","journal-title":"Hum Mol Genet"},{"issue":"11","key":"4330_CR59","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.4049\/jimmunol.1302896","volume":"192","author":"ER Allan","year":"2014","unstructured":"Allan ER, Tailor P, Balce DR, Pirzadeh P, McKenna NT, Renaux B et al (2014) NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing. J Immunol 192(11):4989\u20135001","journal-title":"J Immunol"},{"key":"4330_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.948297","volume":"13","author":"S D'Amico","year":"2022","unstructured":"D\u2019Amico S, Tempora P, Melaiu O, Lucarini V, Cifaldi L, Locatelli F et al (2022) Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy. Front Immunol 13:948297","journal-title":"Front Immunol"},{"issue":"8","key":"4330_CR61","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.4049\/jimmunol.1900778","volume":"204","author":"AM Johnson","year":"2020","unstructured":"Johnson AM, Bullock BL, Neuwelt AJ, Poczobutt JM, Kaspar RE, Li HY et al (2020) Cancer cell-intrinsic expression of MHC class II regulates the immune microenvironment and response to anti-PD-1 therapy in lung adenocarcinoma. J Immunol 204(8):2295\u20132307","journal-title":"J Immunol"},{"issue":"13","key":"4330_CR62","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1158\/0008-5472.CAN-12-0299","volume":"72","author":"K Mima","year":"2012","unstructured":"Mima K, Okabe H, Ishimoto T, Hayashi H, Nakagawa S, Kuroki H et al (2012) CD44s regulates the TGF-beta-mediated mesenchymal phenotype and is associated with poor prognosis in patients with hepatocellular carcinoma. Cancer Res 72(13):3414\u20133423","journal-title":"Cancer Res"},{"key":"4330_CR63","doi-asserted-by":"crossref","unstructured":"Brown NF, Marshall JF. (2019) Integrin-Mediated TGFbeta Activation Modulates the Tumour Microenvironment. Cancers (Basel) 11(9)","DOI":"10.3390\/cancers11091221"},{"issue":"16","key":"4330_CR64","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.13794","volume":"6","author":"KA Correll","year":"2018","unstructured":"Correll KA, Edeen KE, Redente EF, Zemans RL, Edelman BL, Danhorn T et al (2018) TGF beta inhibits HGF, FGF7, and FGF10 expression in normal and IPF lung fibroblasts. Physiol Rep 6(16):e13794","journal-title":"Physiol Rep"},{"issue":"1","key":"4330_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00418-4","volume":"7","author":"H Al-Sudani","year":"2023","unstructured":"Al-Sudani H, Ni Y, Jones P, Karakilic H, Cui L, Johnson LDS et al (2023) Targeting CD47-SIRPa axis shows potent preclinical anti-tumor activity as monotherapy and synergizes with PARP inhibition. NPJ Precis Oncol 7(1):69","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"4330_CR66","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41467-019-14060-x","volume":"11","author":"M Yu","year":"2020","unstructured":"Yu M, Guo G, Huang L, Deng L, Chang CS, Achyut BR et al (2020) CD73 on cancer-associated fibroblasts enhanced by the A(2B)-mediated feedforward circuit enforces an immune checkpoint. Nat Commun 11(1):515","journal-title":"Nat Commun"},{"issue":"11","key":"4330_CR67","doi-asserted-by":"publisher","first-page":"7430","DOI":"10.1074\/jbc.R112.444158","volume":"288","author":"HL Fu","year":"2013","unstructured":"Fu HL, Valiathan RR, Arkwright R, Sohail A, Mihai C, Kumarasiri M et al (2013) Discoidin domain receptors: unique receptor tyrosine kinases in collagen-mediated signaling. J Biol Chem 288(11):7430\u20137437","journal-title":"J Biol Chem"},{"issue":"5","key":"4330_CR68","doi-asserted-by":"publisher","first-page":"311","DOI":"10.5483\/BMBRep.2010.43.5.311","volume":"43","author":"YH Soung","year":"2010","unstructured":"Soung YH, Clifford JL, Chung J (2010) Crosstalk between integrin and receptor tyrosine kinase signaling in breast carcinoma progression. BMB Rep 43(5):311\u2013318","journal-title":"BMB Rep"},{"issue":"1","key":"4330_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01259-6","volume":"8","author":"X Pang","year":"2023","unstructured":"Pang X, He X, Qiu Z, Zhang H, Xie R, Liu Z et al (2023) Targeting integrin pathways: mechanisms and advances in therapy. Signal Transduct Target Ther 8(1):1","journal-title":"Signal Transduct Target Ther"},{"issue":"69","key":"4330_CR70","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi4613","volume":"7","author":"JM Moreau","year":"2022","unstructured":"Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z (2022) Transforming growth factor-beta1 in regulatory T cell biology. Sci Immunol 7(69):eabi4613","journal-title":"Sci Immunol"},{"key":"4330_CR71","doi-asserted-by":"crossref","unstructured":"Li A, Chang Y, Song NJ, Wu X, Chung D, Riesenberg BP, et al. (2022) Selective targeting of GARP-LTGFbeta axis in the tumor microenvironment augments PD-1 blockade via enhancing CD8(+) T cell antitumor immunity. J Immunother Cancer 10(9)","DOI":"10.1136\/jitc-2022-005433"},{"key":"4330_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.891268","volume":"13","author":"B Chen","year":"2022","unstructured":"Chen B, Mu C, Zhang Z, He X, Liu X (2022) The love-hate relationship between TGF-beta signaling and the immune system during development and tumorigenesis. Front Immunol 13:891268","journal-title":"Front Immunol"},{"key":"4330_CR73","doi-asserted-by":"crossref","unstructured":"Tolcher AW, Gordon M, Mahoney KM, Seto A, Zavodovskaya M, Hsueh CH, et al. (2023) Phase 1 first-in-human study of dalutrafusp alfa, an anti-CD73-TGF-beta-trap bifunctional antibody, in patients with advanced solid tumors. J Immunother Cancer 11(2)","DOI":"10.1136\/jitc-2022-005267"},{"issue":"1","key":"4330_CR74","doi-asserted-by":"publisher","first-page":"3236","DOI":"10.1038\/s41467-021-23331-5","volume":"12","author":"L Giuffrida","year":"2021","unstructured":"Giuffrida L, Sek K, Henderson MA, Lai J, Chen AXY, Meyran D et al (2021) CRISPR\/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy. Nat Commun 12(1):3236","journal-title":"Nat Commun"},{"issue":"11","key":"4330_CR75","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1158\/1535-7163.MCT-23-0843","volume":"23","author":"K Schiemann","year":"2024","unstructured":"Schiemann K, Belousova N, Matevossian A, Nallaparaju KC, Kradjian G, Pandya M et al (2024) Dual A2A\/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo. Mol Cancer Ther 23(11):1517\u20131529","journal-title":"Mol Cancer Ther"},{"key":"4330_CR76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI190841","author":"J Ahn","year":"2025","unstructured":"Ahn J, Xie P, Chen S, Shi G, Fan J, Zhang M et al (2025) 4-1BB stimulation with concomitant inactivation of adenosine A2B receptors enhances CD8+ T cell antitumor response. J Clin Invest. https:\/\/doi.org\/10.1172\/JCI190841","journal-title":"J Clin Invest"},{"issue":"1","key":"4330_CR77","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","volume":"141","author":"BZ Qian","year":"2010","unstructured":"Qian BZ, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39\u201351","journal-title":"Cell"},{"issue":"6","key":"4330_CR78","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1007\/s10637-025-01591-y","volume":"43","author":"DH Owen","year":"2025","unstructured":"Owen DH, Wu R, Wei L, Dikov M, Suman S, Su PL et al (2025) Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer. Invest New Drugs 43(6):1211\u20131221","journal-title":"Invest New Drugs"},{"issue":"7152","key":"4330_CR79","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/nature06013","volume":"448","author":"A Takaoka","year":"2007","unstructured":"Takaoka A, Wang Z, Choi MK, Yanai H, Negishi H, Ban T et al (2007) DAI (DLM-1\/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448(7152):501\u2013505","journal-title":"Nature"},{"issue":"10","key":"4330_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.559","volume":"8","author":"J Zhang","year":"2017","unstructured":"Zhang J, Zhang Y, Wu W, Wang F, Liu X, Shui G et al (2017) Guanylate-binding protein 2 regulates Drp1-mediated mitochondrial fission to suppress breast cancer cell invasion. Cell Death Dis 8(10):e3151","journal-title":"Cell Death Dis"},{"key":"4330_CR81","doi-asserted-by":"crossref","unstructured":"Lu SX, De Neef E, Thomas JD, Sabio E, Rousseau B, Gigoux M, et al. (2021) Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell 184(15):4032\u201347 e31","DOI":"10.1016\/j.cell.2021.05.038"},{"issue":"6","key":"4330_CR82","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1158\/2326-6066.CIR-22-0290","volume":"11","author":"R Diwanji","year":"2023","unstructured":"Diwanji R, O\u2019Brien NA, Choi JE, Nguyen B, Laszewski T, Grauel AL et al (2023) Targeting the IL1beta Pathway for Cancer Immunotherapy Remodels the Tumor Microenvironment and Enhances Antitumor Immune Responses. Cancer Immunol Res 11(6):777\u2013791","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"4330_CR83","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.4049\/jimmunol.1501139","volume":"195","author":"HB Cohen","year":"2015","unstructured":"Cohen HB, Ward A, Hamidzadeh K, Ravid K, Mosser DM (2015) IFN-gamma prevents adenosine receptor (A2bR) upregulation to sustain the macrophage activation response. J Immunol 195(8):3828\u20133837","journal-title":"J Immunol"},{"key":"4330_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0154-9","volume":"4","author":"I Montalban Del Barrio","year":"2016","unstructured":"Montalban Del Barrio I, Penski C, Schlahsa L, Stein RG, Diessner J, Wockel A et al (2016) Adenosine-generating ovarian cancer cells attract myeloid cells which differentiate into adenosine-generating tumor associated macrophages - a self-amplifying, CD39- and CD73-dependent mechanism for tumor immune escape. J Immunother Cancer 4:49","journal-title":"J Immunother Cancer"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-026-04330-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-026-04330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T11:37:29Z","timestamp":1772278649000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-026-04330-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["4330"],"URL":"https:\/\/doi.org\/10.1007\/s00262-026-04330-1","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"All animal work was done with Institutional Animal Care and Use Committee (IACUC) approval of The Ohio State University, following the established guidelines, ID#:2013A00000131-R3.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have agreed to publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"90"}}